Psoriasis treatment patterns with etanercept and adalimumab in a United States health plan population

By Chastek Benjamin  

Journal of Dermatological Treatment, Vol. 24, Iss. 1, 2013-02 ,pp. : 25-33

Informa Healthcare

Access to resources Recommend Favorite

The Combination of Etanercept and Methotrexate Increases the Effectiveness of Treatment in Active Psoriasis Despite Inadequate Effect of Methotrexate Therapy

By Zachariae Claus   Mørk Nils-Jørgen   Reunala Timo   Lorentzen Henrik   Falk Edvard   Karvonen Seija-Liisa   Johannesson Anders   Claréus Birgitta   Skov Lone   Mørk Gro   Walker Siân   Qvitzau Susanne  

Acta Dermato-Venereologica, Vol. 88, Iss. 5, 2008-09 ,pp. : 495-501

Medical Journals Limited

Access to resources Recommend Favorite

Etanercept and efalizumab treatment for high-need psoriasis. Effects and side effects in a prospective cohort study in outpatient clinical practice

By Berends Maartje A. M.   Driessen Rieke J. B.   Langewouters Annechien M. G.   Boezeman Jan B.   van de Kerkhof Peter C. M.   de Jong Elke M. G. J.  

Journal of Dermatological Treatment, Vol. 18, Iss. 2, 2007-01 ,pp. : 76-83

Informa Healthcare

Access to resources Recommend Favorite

Cytomegalovirus Complicating Biological Immunosuppressive Therapy in Two Patients with Psoriasis Receiving Treatment with Etanercept or Efalizumab

By Petersen Bibi   Lorentzen Henrik  

Acta Dermato-Venereologica, Vol. 88, Iss. 5, 2008-09 ,pp. : 523-524

Medical Journals Limited

Access to resources Recommend Favorite

Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence

By Strohal Robert  

Journal of Dermatological Treatment, Vol. 24, Iss. 3, 2013-06 ,pp. : 199-208

Informa Healthcare

Access to resources Recommend Favorite